Biota Pharmaceuticals, Inc. clinical trials
Acquired by Vaxart, Feb 13, 2018 · source ↗
The registry lists 4 studies whose lead sponsor is Biota Pharmaceuticals, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 1, 2018.
Before and after it joined Vaxart
- First submitted before Biota Pharmaceuticals, Inc. became part of Vaxart
- 4
- First submitted after Biota Pharmaceuticals, Inc. became part of Vaxart
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Biota Pharmaceuticals, Inc.4 studies
Something wrong with this grouping? Tell us on the Vaxart page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Vaxart studies →
- A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus InfectionCompletedNCT02367313Phase 2
Sponsor listed in the registry: Biota Pharmaceuticals, Inc. · First submitted before Biota Pharmaceuticals, Inc. became part of Vaxart
- A Study to Compare the Oral Bioavailability of Single Doses of Two Vapendavir Drug Formulations in Healthy VolunteersCompletedNCT02101866Phase 1
Sponsor listed in the registry: Biota Pharmaceuticals, Inc. · First submitted before Biota Pharmaceuticals, Inc. became part of Vaxart
- Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy VolunteersCompletedNCT02668367Phase 1
Sponsor listed in the registry: Biota Pharmaceuticals, Inc. · First submitted before Biota Pharmaceuticals, Inc. became part of Vaxart
- Phase 1 Safety and Pharmacokinetics Study of Single Ascending Doses of BTA-C585 in Healthy VolunteersCompletedNCT02558413Phase 1
Sponsor listed in the registry: Biota Pharmaceuticals, Inc. · First submitted before Biota Pharmaceuticals, Inc. became part of Vaxart